Increased rates of survival of patients diagnosed with childhood cancer presents an opportunity to assess long-term effects of treatments. Bone health has been identified as one of the processes impacted by cancer treatment. Bone densitometry is a tool used for patients currently undergoing treatment for childhood cancer and hematologic diseases such as sickle cell disease and those having completed therapy. This discussion will focus on the methods used to measure bone health and some of the challenges involved in doing so. Read More

Meeting name: SPR 2020 Annual Meeting & Postgraduate Course , 2020

Authors: Snider Terry

Keywords: Bone Densitometry, Childhood cancer